There are currently no effective treatments for the core symptoms of autism spectrum disorder (ASD), such as difficulties with socializing and communicating. A new study uses a computer-based protein interaction network to ...
Sep 12, 2022
0
291
The HEALEY ALS Platform Trial led by the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital in collaboration with the Northeast ALS Consortium (NEALS) is a trial in which multiple investigational products ...
Jul 12, 2022
0
2
New insights into how genetic factors affect the body's immune response in type 1 diabetes have been published in eLife.
Jun 7, 2022
0
18
Griffith University researchers have developed a potential vaccine for a pathogen that causes severe infection in immunocompromised people and is particularly prevalent in hospitals.
Apr 13, 2022
0
8
An important aspect of drug discovery involves determining how well a drug binds to its target (protein) molecule. Typically, this step involves aligning a 3D structure of a drug and its target protein at various configurations ...
Apr 5, 2022
0
1
While vaccination and public education concerning the transmission of the coronavirus causing COVID-19 have been at the forefront of our response to the pandemic, there remains an urgent need for pharmaceutical interventions ...
Mar 24, 2022
0
2
An anti-inflammatory drug candidate, known as 3,6'-dithiopomalidomide (DP) and designed by researchers at the National Institute on Aging (NIA), protected lab mice against cognitive decline by reducing brain inflammation. ...
Mar 2, 2022
0
20
It takes 10 to 15 years and around US$1 billion to develop one successful drug. Despite these significant investments in time and money, 90% of drug candidates in clinical trials fail. Whether because they don't adequately ...
Feb 24, 2022
0
15
Using a stem-cell-derived model, researchers have identified two drug candidates that may slow dry age-related macular degeneration (AMD), a leading cause of blindness for which no treatment exists. The scientists, from the ...
Dec 15, 2021
0
54
Rice University researchers have introduced an online portal to help researchers screen COVID-19 drug candidates that might attack specific proteins of the SARS-CoV-2 virus.
Nov 1, 2021
0
3
